{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.3616.200.110.102.10000","meta":{"versionId":"6","lastUpdated":"2021-04-08T09:02:58.000-04:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.10000","version":"Draft","name":"SARS CoV 2 Vaccines, All","status":"draft","date":"2021-04-08T09:02:57-04:00","publisher":"Clinical Architecture","compose":{"include":[{"system":"http://hl7.org/fhir/sid/cvx","version":"20220412","concept":[{"code":"207","display":"SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL dose"},{"code":"208","display":"SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose"},{"code":"210","display":"SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-ChAdOx1, preservative free, 0.5 mL"},{"code":"212","display":"SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-Ad26, preservative free, 0.5 mL"},{"code":"213","display":"SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED"}]}]}}